Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.56 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.56 |
| ▸ | NPY4R | P50391 | 4/20 | 0.55 |
| ▸ | NPY1R | P25929 | 3/20 | 0.55 |
| ▸ | NPY2R | P49146 | 3/20 | 0.55 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.52 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.48 |
| ▸ | CHRNG | P07510 | 1/20 | 0.48 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.48 |
| ▸ | CHRND | Q07001 | 1/20 | 0.48 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.48 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.48 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31135152 | 1.00 | ERAP2 (0.56) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL31031465 | 0.98 | ERAP2 (0.54) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL30973975 | 0.98 | ERAP2 (0.54) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL29680070 | 0.94 | NPY1R (0.56) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL30974367 | 0.93 | NPY4R (0.58) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| Lysyl-Tyrosyl-Lysine Acetate SCHEMBL6275116 | 0.93 | NPY4R (0.62) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL30523264 | 0.93 | LNPEP (0.63) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| Lysyl-Tyrosyl-Lysine Acetate SCHEMBL6275111 | 0.93 | NPY4R (0.62) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL27942027 | 0.93 | NPY4R (0.62) | ERAP2LNPEPNPY4RNPY1RNPY2R | |
| SCHEMBL30931517 | 0.92 | LNPEP (0.62) | ERAP2LNPEPNPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250324933-A1 | Crown Rot Resistance | COMMW SCIENT IND RES ORG (AU) | 2025-10-23 | — | — | US | disclosed |
| US-20250188500-A1 | METHODS AND SYSTEMS FOR DEPOLYMERIZING POLYAMIDES | Alliance for Energy Innovation, LLC | 2025-06-12 | — | — | US | disclosed |
| CN-116200352-B | 7 Alpha-hydroxysteroid dehydrogenase mutant and application thereof in 7-oxo-lithocholic acid synthesis | 江南大学 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025064408-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE | THE BROAD INSTITUTE, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025044960-A1 | KETOREDUCTASE MUTANT AND USE THEREOF | 华南理工大学 | 2025-03-06 | — | — | WO | disclosed |
| US-12138285-B2 | Cholesterol reducing compositions and methods of use thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-11-12 | — | — | US | disclosed |
| CN-118524779-A | Crown rot resistance | 联邦科学技术研究组织 | 2024-08-20 | — | — | CN | disclosed |
| CN-113151205-B | Alcohol dehydrogenase mutant and application thereof in synthesis of cyclic terpene ketone | 苏州百福安酶技术有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-4391796-A1 | CROWN ROT RESISTANCE | Commonwealth Scientific and Industrial Research Organisation (AU) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024132726-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | disclosed |
| CN-117126823-B | Ketone reductase mutant and application thereof | 华南理工大学 | 2024-03-29 | — | — | CN | disclosed |
| US-20240024381-A1 | CHOLESTEROL REDUCING COMPOSITIONS AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-01-25 | — | — | US | disclosed |
| CN-117126823-A | Ketone reductase mutant and application thereof | 华南理工大学 | 2023-11-28 | — | — | CN | disclosed |
| CN-116200352-A | 7 alpha-hydroxysteroid dehydrogenase mutant and application thereof in 7-oxo-lithocholic acid synthesis | 江南大学 | 2023-06-02 | — | — | CN | disclosed |
| US-11633436-B2 | Cholesterol reducing compositions and methods of use thereof | THE BROAD INSTITUTE, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| WO-2023023719-A1 | CROWN ROT RESISTANCE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024381-A1 | CHOLESTEROL REDUCING COMPOSITIONS AND METHODS OF USE THEREOF | CETP, DHCR7, HMGCR | ERAP2 2066/4885LNPEP 1161/4885NPY4R 4714/4885 |
| US-11633436-B2 | Cholesterol reducing compositions and methods of use thereof | CETP, DHCR7, HMGCR | ERAP2 2066/4885LNPEP 1161/4885NPY4R 4714/4885 |
| US-12138285-B2 | Cholesterol reducing compositions and methods of use thereof | CETP, DHCR7, HMGCR | ERAP2 2066/4885LNPEP 1161/4885NPY4R 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.